| 000 | 01791 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250517123655.0 | ||
| 264 | 0 | _c20170523 | |
| 008 | 201705s 0 0 eng d | ||
| 022 | _a1532-1827 | ||
| 024 | 7 |
_a10.1038/bjc.2016.348 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLedermann, Jonathan A | |
| 245 | 0 | 0 |
_aQuality of life during olaparib maintenance therapy in platinum-sensitive relapsed serous ovarian cancer. _h[electronic resource] |
| 260 |
_bBritish journal of cancer _cNov 2016 |
||
| 300 |
_a1313-1320 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Recurrence, Local |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aPhthalazines _xadverse effects |
| 650 | 0 | 4 |
_aPiperazines _xadverse effects |
| 650 | 0 | 4 | _aPlacebos |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aHarter, Philipp | |
| 700 | 1 | _aGourley, Charlie | |
| 700 | 1 | _aFriedlander, Michael | |
| 700 | 1 | _aVergote, Ignace | |
| 700 | 1 | _aRustin, Gordon | |
| 700 | 1 | _aScott, Clare | |
| 700 | 1 | _aMeier, Werner | |
| 700 | 1 | _aShapira-Frommer, Ronnie | |
| 700 | 1 | _aSafra, Tamar | |
| 700 | 1 | _aMatei, Daniela | |
| 700 | 1 | _aFielding, Anitra | |
| 700 | 1 | _aBennett, Bryan | |
| 700 | 1 | _aParry, David | |
| 700 | 1 | _aSpencer, Stuart | |
| 700 | 1 | _aMann, Helen | |
| 700 | 1 | _aMatulonis, Ursula | |
| 773 | 0 |
_tBritish journal of cancer _gvol. 115 _gno. 11 _gp. 1313-1320 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/bjc.2016.348 _zAvailable from publisher's website |
| 999 |
_c26587046 _d26587046 |
||